购物车
- 全部删除
- 您的购物车当前为空
Oxyphenisatin acetate 是oxyphenisatin 的前体药物,可抑制乳腺癌细胞系 MCF7、T47D、HS578T 和 MDA-MB-468 的生长。
为众多的药物研发团队赋能,
让新药发现更简单!
Oxyphenisatin acetate 是oxyphenisatin 的前体药物,可抑制乳腺癌细胞系 MCF7、T47D、HS578T 和 MDA-MB-468 的生长。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 153 | 现货 | |
10 mg | ¥ 248 | 现货 | |
25 mg | ¥ 393 | 现货 | |
50 mg | ¥ 548 | 现货 | |
100 mg | ¥ 798 | 现货 | |
500 mg | ¥ 1,990 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 232 | 现货 |
产品描述 | Oxyphenisatin acetate inhibits the growth of the breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468. |
体外活性 | 在雌激素受体(ER)阳性的MCF7和T47D细胞中,OXY诱导TNFα表达和TNFR1降解,表明这些细胞系中发生了自分泌受体介导的凋亡。最后,在MCF7异种移植模型中,腹腔内给予OXY抑制了肿瘤生长,伴随eIF2α的磷酸化和TNFR1的降解。OXY引发的多方面细胞饥饿反应,最终诱导程序性细胞死亡[1]。 |
细胞实验 | Total RNA was isolated from MCF7 cells treated with 10 μmol/L OXY for 24 h and the microarray procedure performed as described previously using the GeneChip Human U133 plus 2.0 array . Pairwise analysis was performed on control versus treated arrays using a fivefold change cutoff, <0.01 adjusted P-value, GC-RMA normalization with Benjamini–Hochberg false discovery estimation[1]. |
别名 | 双醋酚丁 |
分子量 | 401.41 |
分子式 | C24H19NO5 |
CAS No. | 115-33-3 |
存储 | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 150 mg/mL (373.68 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.